SEC Form 4 · accession 0001209191-17-010890
ARENA PHARMACEUTICALS INC · ARNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jayson Donald Alexander Dallas
Director
Period of report
Feb 13, 2017
Accepted (ET)
Feb 14, 2017 · 8:16 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001080709
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $1.46 | Feb 13, 2017 | A | 75,000 | A | — | Feb 13, 2024 | Common Stock | 75,000 | 75,000 | D |
| Employee Stock Option (right to buy)F2 | $1.46 | Feb 13, 2017 | A | 41,666 | A | — | Feb 13, 2024 | Common Stock | 41,666 | 41,666 | D |
Explanation of responses
- F1The options vest over one year with one twelfth vesting on March 13, 2017, and the remainder of the shares vesting monthly over the following eleven months in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.
- F2The options vest over four months with 25% vesting on March 13, 2017, and the remainder of the shares vesting monthly over the following three months in equal installments (except as otherwise necessary to avoid vesting of a fractional share), and are exercisable once vested.